Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aspirin may reduce cancer mortality

This article was originally published in The Tan Sheet

Executive Summary

Regular aspirin use may lower the risk of cancer-specific mortality among patients diagnosed with nonmetastatic colorectal cancer, according to a Journal of the American Medical Association study. Of the 840 women and 439 men participating in the Nurses' Health Study and the Health Professionals Follow-Up Study, 222 died from colorectal cancer. Only 15 percent of these deaths occurred among regular aspirin users, whereas 19 percent of deaths occurred among subjects who did not regularly use aspirin after their diagnosis, according to lead researcher Andrew Chan of Massachusetts General Hospital and Harvard Medical School and his associates. The results suggest this cancer type is sensitive to aspirin's potential anticancer effect, though cyclo-oxygenase-2-negative tumors might be aspirin-resistant

Related Content

Study Suggests Aspirin Use Enhances Survival After Breast Cancer





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts